Platelet-Function Testing in Patients Undergoing Neurovascular Procedures: Caught between a Rock and a Hard Place

被引：28
作者：
Comin, J. [2 ]
Kallmes, D. F. [1 ]
机构：
[1] Mayo Clin, Dept Radiol, Rochester, MN USA
[2] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia
来源：
AMERICAN JOURNAL OF NEURORADIOLOGY | 2013年 / 34卷 / 04期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; VASODILATOR-STIMULATED PHOSPHOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ELUTING STENT THROMBOSIS; OF-CARE ASSAY; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL NONRESPONDERS; RANDOMIZED-TRIAL;
D O I：
10.3174/ajnr.A3440
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In the context of neurointerventional procedures, clopidogrel hyper-responsiveness has been associated with hemorrhage; on the other hand, clopidogrel resistance has been associated with thromboembolism. This might seem to make a compelling argument in favor of routine platelet testing. Our reading of the literature leads us to conclude that routine platelet testing in neurointerventional procedures is not, unfortunately, ready for prime time.
引用
收藏
页码：730 / 734
页数：5
相关论文
共 49 条
[1]   Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis - A case-control study [J].
Ajzenberg, N ;
Aubry, P ;
Huisse, MG ;
Cachier, A ;
El Amara, W ;
Feldman, LJ ;
Himbert, D ;
Baruch, D ;
Guillin, MC ;
Steg, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) :1753-1756
[2]   Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention Results From the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) Randomized Study [J].
Aleil, Boris ;
Jacquemin, Laurent ;
De Poli, Fabien ;
Zaehringer, Michel ;
Collet, Jean-Philippe ;
Montalescot, Gilles ;
Cazenave, Jean-Pierre ;
Dickele, Marie-Claude ;
Monassier, Jean-Pierre ;
Gachet, Christian .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) :631-638
[3]   Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment [J].
Angiolillo, DJ ;
Fernandez-Ortiz, A ;
Bernardo, E ;
Ramírez, C ;
Sabaté, M ;
Jimenez-Quevedo, P ;
Hernández, R ;
Moreno, R ;
Escaned, J ;
Alfonso, F ;
Bañuelos, C ;
Costa, MA ;
Bass, TA ;
Macaya, C .
DIABETES, 2005, 54 (08) :2430-2435
[4]   A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study [J].
Angiolillo, Dominick J. ;
Capranzano, Piera ;
Goto, Shinya ;
Aslam, Mohammed ;
Desai, Bhaloo ;
Charlton, Ronald K. ;
Suzuki, Yoshie ;
Box, Lyndon C. ;
Shoemaker, Steven B. ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. .
EUROPEAN HEART JOURNAL, 2008, 29 (18) :2202-2211
[5]   Functional effects of high Clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment [J].
Angiolillo, Dominick J. ;
Costa, Marco A. ;
Shoemaker, Steven B. ;
Desai, Bhaloo ;
Bernardo, Esther ;
Suzuki, Yoshie ;
Charlton, Ronald K. ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (04) :440-445
[6]   Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials [J].
Angiolillo, Dominick J. ;
Schneider, David J. ;
Bhatt, Deepak L. ;
French, William J. ;
Price, Matthew J. ;
Saucedo, Jorge F. ;
Shaburishvili, Tamaz ;
Huber, Kurt ;
Prats, Jayne ;
Liu, Tiepu ;
Harrington, Robert A. ;
Becker, Richard C. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (01) :44-55
[7]  
Aradi D, 2012, INT J CARDIOL
[8]   Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity [J].
Aradi, Daniel ;
Rideg, Orsolya ;
Vorobcsuk, Andres ;
Magyarlaki, Tamas ;
Magyari, Balazs ;
Konyi, Attila ;
Pinter, Tuende ;
Horvath, Ivan G. ;
Komocsi, Andras .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) :384-392
[9]   The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial) [J].
Ari, Hasan ;
Ozkan, Hakan ;
Karacinar, Ali ;
Ari, Selma ;
Koca, Vedat ;
Bozat, Tahsin .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (03) :374-380
[10]   The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis [J].
Blindt, Ruediger ;
Stellbrink, Katja ;
de Taeye, Anita ;
Mueller, Robert ;
Kiefer, Paul ;
Yagmur, Eray ;
Weber, Christian ;
Kelm, Malte ;
Hoffmann, Rainer .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (06) :1329-1334
12345